NZ Herald
  • Home
  • Latest news
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather forecasts

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
    • The Great NZ Road Trip
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
    • Cooking the Books
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • What the Actual
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / New Zealand

'Left on the scrapheap': Pharmac decision bittersweet for MS patients

NZ Herald
7 Oct, 2019 12:30 AM5 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Pharmac has confirmed it will fund Kadcyla and two other treatments.

Pharmac has confirmed it will fund Kadcyla and two other treatments.

A Motueka grandmother says the national drug-buying agency is abandoning her on the scrapheap with "inhumane" testing criteria for who can get a new multiple sclerosis drug.

Pharmac on Monday confirmed it would fund three new medicines it proposed covering in August for lung cancer, breast cancer and multiple sclerosis.

While Multiple Sclerosis New Zealand has welcomed the announcement that the drug Ocrevus will now be publicly funded – it previously cost individuals about $24,000 a year – for the most common form of MS, it's worried more than 600, or 15 per cent, of patients with a different form of the disease will miss out over what it says are "out-dated" criteria.

READ MORE:
• Opposition turns its sights on Pharmac funding
• Pharmac reveals new cancer drugs on the way, contraception more available
• Premium - Pharmac funding: How it works - and the changes its critics want
• Pharmac changes funding processes for greater transparency

MSNZ's national manger, Amanda Rose, said Pharmac's rules were "inhumanely strict", and even those with the condition covered – Relapsing Remitting Multiple Sclerosis (RRMS) - were made to annually prove they could walk 500 metres unaided as part of a disability scale test.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

"Several leading international experts have expressed astonishment at the strict criteria MS patients here in New Zealand are subjected to," she said.

Motueka woman Lesley Jackson had been running her own vineyard when she was diagnosed with MS seven years ago at age 52.

Motueka woman Lesley Jackson has criticised what she calls the Pharmac "Walk of Shame". Photo / Supplied
Motueka woman Lesley Jackson has criticised what she calls the Pharmac "Walk of Shame". Photo / Supplied

Three years ago she was taken off the last drug she had been prescribed because her condition had deteriorated too much.

Advertisement
Advertise with NZME.

"I feel like I've just been thrown on the scrapheap," she said.

Jackson labelled the walking test "the Pharmac walk of shame".

"I vomited the last time I lined up for the walk and was unable to even start it," she said.

"I've seen grown men cry having to face it. Nowhere else in the OECD is anyone made to sit this test - it's inhumane."

Discover more

New Zealand|politics

No breast cancer drug decision yet, says Pharmac

24 Apr 05:07 AM
New Zealand|politics

Cancer sufferers applaud National's cancer-care policy

28 Jul 12:09 AM
New Zealand

Family says proposed cancer drugs funding would be 'life-changing'

07 Aug 08:13 AM

In a statement, a Pharmac spokeswoman said the agency's experts had concluded Ocrevus was not appropriate as a treatment for all kinds of MS.

"This was largely because of the lack of data to establish both the safety and efficacy of ocrelizumab for people with primary progressive multiple sclerosis," she said.

She said the agency had found other forms of testing were "impractical and would likely lead to patients stopping treatment earlier".

The drug-buying agency announced on Monday it would also be funding Kadcyla – a treatment for metastatic breast cancer that was in 2018 subject to a petition to Parliament – along with the lung cancer drug Alecensa.

All three treatments will be publicly available from December 1.

"These medicines are going to make a real difference to the lives of people who, in some cases, are living with very severe conditions and symptoms," Pharmac's acting medical director Ken Clarke said.

Advertisement
Advertise with NZME.

Campaigners have for about a year been pressing the Government agency to pick up the tab for Kadcyla and another drug, Ibrance, which could prolong the lives of women with advanced breast cancer, which are publicly funded in Australia.

More than 600 Kiwi women die each year from breast cancer, the nation's third most common form of cancer.

Malcolm Mulholland's wife, Wiki, was among the women who last year urged politicians to fund the breast cancer medications. She's among hundreds who can't take Kadcyla and are still waiting on a decision about Ibrance.

Pharmac is due to make a final call on that drug by April.

"It's a good decision that will benefit many women, not just now but in generations to come," Mulholland said of Monday's decision.

But he questions why the process has taken so long, compared to similar agencies in Australia and Britain, and only came after lobbying.

Advertisement
Advertise with NZME.

"No one should have to go through what we've gone through to get a drug funded," he said.

In August he submitted a new petition to Parliament, calling for Pharmac's billion-dollar-a-year budget to be tripled within two years.

Separately, the Lung Foundation this year launched a petition calling for more funding from Pharmac, saying only about 2 per cent of the funding Pharmac spends on the top five cancer treatments went to lung cancer.

That's despite the disease killing five people a day.

The foundations' chief executive, Philip Hope, said Monday's decision would prevent the premature deaths of eight lung cancer patients a month.

"We still have concerns around the unnecessary delay and tactics being used by Pharmac before they finally make decisions in line with international standards," he said.

Advertisement
Advertise with NZME.

"Sadly, New Zealand is still dragging the chain when it comes to providing access to precision treatments."

Prime Minister Jacinda Ardern said while the Pharmac model was more effective than some of its overseas counterparts, it hadn't always kept pace on early access to some emerging drugs.

"We are looking at whether or not we can create an early access model, something like the UK has," she said.

But she said decisions about what drugs to fund had to ultimately come from the agency, and could not be subject to pressure from politicians or pharmaceutical companies.

The Government in June announced it was putting an extra $60 million into Pharmac's billion-dollar-a-year budget. That came after criticism from the Opposition that it had only increased the agency's funding by $10 million in the national Budget in May .

Save

    Share this article

Latest from New Zealand

New ZealandUpdated

Flights delayed at Auckland Airport as intense rain batters city, sparking surface flooding

09 May 05:38 AM
Crime

Avondale man accused of murdering partner loses name suppression

09 May 05:38 AM
New Zealand

First stage of Tarawera sewerage scheme complete

09 May 05:17 AM

One tiny baby’s fight to survive

sponsored
Advertisement
Advertise with NZME.

Latest from New Zealand

Flights delayed at Auckland Airport as intense rain batters city, sparking surface flooding

Flights delayed at Auckland Airport as intense rain batters city, sparking surface flooding

09 May 05:38 AM

Motorists are being warned to expect hazardous driving conditions.

Avondale man accused of murdering partner loses name suppression

Avondale man accused of murdering partner loses name suppression

09 May 05:38 AM
First stage of Tarawera sewerage scheme complete

First stage of Tarawera sewerage scheme complete

09 May 05:17 AM
'Held together by wire': Mechanic's quick-fix on broken fire truck labelled 'Kiwi ingenuity'

'Held together by wire': Mechanic's quick-fix on broken fire truck labelled 'Kiwi ingenuity'

09 May 05:06 AM
Connected workers are safer workers 
sponsored

Connected workers are safer workers 

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • What the Actual
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven CarGuide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP